Literature DB >> 7690489

Prostate cancer and the role of color Doppler US.

I M Kelly1, W R Lees, D Rickards.   

Abstract

PURPOSE: To determine the role of color Doppler imaging (CDI) in diagnosis of prostate cancer.
MATERIALS AND METHODS: Transrectal ultrasound (TRUS) and CDI were performed in 456 patients with possible prostate cancer. Of these patients, 158 underwent prostate biopsy, and these formed the study group.
RESULTS: The frequency of malignancy was 47% (75 of 158). Of 136 TRUS-positive cases, 72 were malignant and 64 benign. Of 84 CDI-positive cases, 65 were malignant and 19 benign (chi 2 = 12.18, P < .001). Thirteen percent of histopathologically proved cases (10 of 75) were normal at CDI. TRUS alone had a sensitivity of 96% and a positive predictive value (PPV) of 0.53. The addition of CDI increased the PPV to 0.77 but reduced the sensitivity to 87%. In only one case out of 158 did CDI suggest the diagnosis of malignancy independently of TRUS.
CONCLUSION: CDI improves the PPV of TRUS but appears to have little additional value over TRUS alone in diagnosis of prostate cancer.

Entities:  

Mesh:

Year:  1993        PMID: 7690489     DOI: 10.1148/radiology.189.1.7690489

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  [Transrectal ultrasound of the prostate. Current status and prospects].

Authors:  M Zacharias; K V Jenderka; H Heynemann; P Fornara
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

Review 2.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

3.  Contrast-enhanced ultrasound imaging of prostate cancer.

Authors:  Ethan J Halpern
Journal:  Rev Urol       Date:  2006

Review 4.  [Ultrasound contrast agents and prostate cancer].

Authors:  F Frauscher; L Pallwein; A Klauser; A P Berger; F Koppelstaetter; J Gradl; M Schurich; J Bektic; G M Pinggera; E J Halpern; W Horninger; G Bartsch; D zur Nedden
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

5.  Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.

Authors:  V A Morgan; S F Riches; K Thomas; N Vanas; C Parker; S Giles; N M Desouza
Journal:  Br J Radiol       Date:  2011-01       Impact factor: 3.039

Review 6.  [Innovative concepts in early cancer detection and staging of localized prostate cancer].

Authors:  L Rinnab; R Küfer; R E Hautmann; B G Volkmer; M Straub; N M Blumstein; H W Gottfried
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

7.  Detecting Cataract Using Smartphones.

Authors:  Behnam Askarian; Peter Ho; Jo Woon Chong
Journal:  IEEE J Transl Eng Health Med       Date:  2021-04-20       Impact factor: 3.316

8.  Prostatic atrophy: evidence for a possible role of local ischemia in its pathogenesis.

Authors:  Luciana R Meirelles; Athanase Billis; Ana C S Cotta; Rui T Nakamura; Nelson M G Caserta; Adilson Prando
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  [Imaging procedures to diagnose prostate cancer].

Authors:  M Seitz; B Scher; M Scherr; D Tilki; B Schlenker; C Gratzke; A Schipf; P Stanislaus; U Müller-Lisse; O Reich; C Stief
Journal:  Urologe A       Date:  2007-10       Impact factor: 0.639

10.  Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer.

Authors:  Masahiko Inahara; Hiroyoshi Suzuki; Hiroshi Nakamachi; Naoto Kamiya; Masaki Shimbo; Akira Komiya; Takeshi Ueda; Tomohiko Ichikawa; Koichiro Akakura; Haruo Ito
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.